mRNA vaccines: The future of prevention of viral infections?
Journal of Medical Virology · 2023-02 · 95 (2)
DOI: 10.1002/jmv.28572 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medical Virology, online erschienen am 20.02.2023. Verfasst von Piotr Rzymski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Medicine, Poznan University of Medical Sciences, Poznań, Poland. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, COVID-19, Virus Diseases, Respiratory Syncytial Virus, Human. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 324 Literaturangaben.
Abstract (Originalsprache)
Messenger RNA (mRNA) vaccines against COVID‐19 are the first authorized biological preparations developed using this platform. During the pandemic, their administration has been proven to be a life‐saving intervention. Here, we review the main advantages of using mRNA vaccines, identify further technological challenges to be met during the development of the mRNA platform, and provide an update on the clinical progress on leading mRNA vaccine candidates against different viruses that include influenza viruses, human immunodeficiency virus 1, respiratory syncytial virus, Nipah virus, Zika virus, human cytomegalovirus, and Epstein‐Barr virus. The prospects and challenges of manufacturing mRNA vaccines in low‐income countries are also discussed. The ongoing interest and research in mRNA technology are likely to overcome some existing challenges for this technology (e.g., related to storage conditions and immunogenicity of some components of lipid nanoparticles) and enhance the portfolio of vaccines against diseases for which classical formulations are already authorized. It may also open novel pathways of protection against infections and their consequences for which no safe and efficient immunization methods are currently available.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Environmental Medicine, Poznan University of Medical Sciences, Poznań, Poland.
- Integrated Science Association (ISA), Universal Scientific Education and Research Network (USERN), Poznań, Poland.
- Department of Virology and Immunology, Institute of Biological Sciences, Maria Curie-Skłodowska University, Lublin, Poland.
- Department of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland.
- Alexander von Humboldt Fellow & Guest Professor, Grassland Science and Renewable Plant Resources, Faculty of Organic Agricultural Sciences, Universität Kassel, Witzenhausen, Germany.
- Alexander von Humboldt Fellow & Guest Professor, Leibniz Institute for Agricultural Engineering and Bioeconomy (ATB), Potsdam, Germany.
ORCID-Profile: Piotr Rzymski
Zitieren
APA
Rzymski, P., Szuster-Ciesielska, A., Dzieciątkowski, T., Gwenzi, W., & Fal, A. (2023). mRNA vaccines: The future of prevention of viral infections?. Journal of Medical Virology, 95(2). https://doi.org/10.1002/jmv.28572
Vancouver
Rzymski P, Szuster-Ciesielska A, Dzieciątkowski T, Gwenzi W, Fal A. mRNA vaccines: The future of prevention of viral infections?. Journal of Medical Virology. 2023;95(2). doi:10.1002/jmv.28572
BibTeX
@article{Rzymski2023,
author = {Rzymski, Piotr and Szuster-Ciesielska, Agnieszka and Dzieciątkowski, Tomasz and Gwenzi, Willis and Fal, Andrzej},
title = {mRNA vaccines: The future of prevention of viral infections?},
journal = {Journal of Medical Virology},
year = {2023},
volume = {95},
number = {2},
doi = {10.1002/jmv.28572}
}
EUVIMED